alexa Chemopreventive Effect Of N-3 PUFAs And Atorvastatin In Rats With Bladder Cancer
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

9th Annual European Pharma Congress
June 26-28, 2017 Madrid, Spain

Eman G Khedr, Nahla E El Ashmawy, Hoda A El Bahrawy and Samar M Al Tantawy
Tanta University, Egypt
Posters & Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689-C1-025
Bladder cancer remains a huge concern for the medical community because of its incidence and prevalence rates, as well as high percentage of recurrence and progression. Omega–3 polyunsatu¬rated fatty acids (n–3 PUFAs) and atorvastatin (ATOR) proved anti-inflammatory effects through PPAR-γ mechanism. However, their chemopreventive effect still remained to be examined and clari¬fied. In the current study, bladder cancer was induced in rats by the chemical carcinogen BBN. n-3 PUFAs (DHA and EPA 2:3 w/w; 1200 mg/kg) and/or ATOR (6 mg/kg) were given orally daily to rats for 8 consecutive weeks concomitantly with BBN, and continued for further 4 weeks after cessa-tion of BBN administration. The histopathological examination of rat bladder revealed presence of tumors and absence of apoptotic bodies in sections from BBN group, while tumors were absent and apoptotic bodies were clearly observed in sections from rat groups treated with n-3 PUFAs, ATOR, or both drugs. The study of the molecular mechanisms illustrated downregulation of COX-2 and P53 (mutant) genes and suppression of TGF–β1 and the lipid peroxidation product malondialdehyde in serum of rats of the three treated groups. This chemopreventive effect was confirmed by and associ¬ated with lower level of bladder tumor antigen (BTA) in urine. However, the combined treatment with both drugs exhibited the major protective effect and nearly corrected the dyslipidemia that has been induced by BBN. Collectively, n-3PUFAs and ATOR, besides having anti-inflammatory proper-ties, proved a chemopreventive effect against bladder cancer, which nominates them to be used as adjuvant therapy with other chemotherapeutics.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version